This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| CDC Streptococcus Laboratory | |
|---|---|
| Name | CDC Streptococcus Laboratory |
| Established | 19XX |
| Location | Atlanta, Georgia |
| Parent | Centers for Disease Control and Prevention |
| Focus | Streptococcus research, surveillance, diagnostics |
CDC Streptococcus Laboratory The CDC Streptococcus Laboratory operates within the Centers for Disease Control and Prevention in Atlanta, providing specialized laboratory science on streptococcal pathogens with roles in surveillance, diagnostics, outbreak response, and guidance. It supports public health action through strain characterization, molecular epidemiology, antimicrobial resistance testing, and development of diagnostic assays that inform policy and practice. The laboratory interacts with clinical partners, academic institutions, international health organizations, and regulatory bodies to translate findings into prevention and control measures.
The laboratory concentrates on clinical and public health aspects of streptococcal species including Group A streptococcus, Group B streptococcus, Streptococcus pneumoniae, and emerging streptococci. It applies genomics, phenotypic assays, whole genome sequencing, antimicrobial susceptibility testing, and serotyping to inform clinical management and vaccine policy. Staff work closely with programs at the Centers for Disease Control and Prevention, collaborating units such as the National Center for Immunization and Respiratory Diseases, and external stakeholders like the World Health Organization, Pan American Health Organization, European Centre for Disease Prevention and Control, and national public health institutes.
Founded to address rising concerns about invasive streptococcal disease, the laboratory evolved alongside milestones including development of penicillin-era testing, advent of pneumococcal conjugate vaccines, and the genomics revolution. Historical interactions include cooperative studies with the National Institutes of Health, Food and Drug Administration, and historically significant investigations that paralleled events like vaccine licensure for pneumococcus, meningococcal and streptococcal epidemiology shifts, and global surveillance expansions. Over decades it expanded capabilities in molecular typing, multilocus sequence typing projects, and next-generation sequencing initiatives tied to major public health events and surveillance programs.
Research programs address pathogenesis, host–pathogen interactions, vaccine antigen discovery, and mechanisms of antimicrobial resistance. Projects have intersected with clinical trials, vaccine efficacy studies, and pathogen discovery efforts supported by collaborators including academic centers such as Johns Hopkins University, Harvard Medical School, Oxford University, Imperial College London, and University of Cape Town. The laboratory’s work informs policy deliberations at advisory bodies such as the Advisory Committee on Immunization Practices and contributes to multi-institutional consortia alongside organizations like the Gates Foundation, Wellcome Trust, and PATH.
The laboratory provides support to national and international surveillance systems, contributing data to networks analogous to Active Bacterial Core surveillance, Global Pneumococcal Sequencing project, and meningitis and neonatal infection surveillance platforms. Diagnostics include culture confirmation, serotyping, emm-typing, whole genome sequencing analysis pipelines, and antimicrobial susceptibility profiling in line with standards from bodies such as Clinical and Laboratory Standards Institute and international reference laboratories. It supplies reference materials and proficiency testing resources to state public health laboratories, clinical laboratories, and global partners including Public Health England, National Institute for Communicable Diseases, and Institut Pasteur.
The laboratory plays a central role in outbreak investigations, providing rapid pathogen characterization and epidemiologic linkage during events such as nosocomial neonatal clusters, community invasive streptococcal outbreaks, and vaccine-preventable disease resurgence. It has supported responses coordinated with entities like the Federal Emergency Management Agency, state health departments, and international emergency response teams. Contributions to policy have included evidence used in treatment guideline updates and vaccine recommendations adopted by institutions and ministries of health worldwide, influenced by data streams similar to those from the Global Influenza Surveillance and Response System and Global Antimicrobial Resistance Surveillance System.
Collaborative networks encompass federal agencies including National Institutes of Health, Food and Drug Administration, and Department of Health and Human Services components; academic partners across continents; and international organizations like World Health Organization, Pan American Health Organization, and European Centre for Disease Prevention and Control. Partnerships extend to nonprofit funders and advocacy groups, public-private vaccine development partnerships, clinical research networks, and reference laboratories such as the Robert Koch Institute, Canadian Institutes of Health Research–supported centers, and national public health institutes from Brazil, South Africa, India, and Australia.
The laboratory leads training for laboratory personnel, epidemiologists, and clinicians through workshops, online modules, and collaborative training programs with institutions including Emory University, Rollins School of Public Health, Johns Hopkins Bloomberg School of Public Health, and regional public health training centers. It issues technical guidance on specimen handling, laboratory methods, and reporting standards used by state and territorial public health laboratories and international partners. Findings are disseminated in peer-reviewed journals and reports that inform policy at bodies such as the Advisory Committee on Immunization Practices, and are cited alongside landmark studies from journals and series produced by collaborators at institutions like the Lancet, New England Journal of Medicine, and Clinical Infectious Diseases.
Category:Public health laboratories Category:Centers for Disease Control and Prevention Category:Infectious disease research institutes